Cerity Partners’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.74M Buy
161,430
+46,035
+40% +$2.02M 0.01% 822
2025
Q4
$4.46M Buy
115,395
+34,420
+43% +$1.31M 0.01% 968
2025
Q3
$2.86M Sell
80,975
-75,555
-48% -$2.74M ﹤0.01% 1121
2025
Q2
$5.64M Buy
156,530
+2,684
+2% +$88.9K 0.01% 751
2025
Q1
$4.79M Buy
153,846
+136,487
+786% +$4.33M 0.01% 749
2024
Q4
$459K Sell
17,359
-15,537
-47% -$412K ﹤0.01% 1814
2024
Q3
$931K Buy
32,896
+3,291
+11% +$91.2K ﹤0.01% 1430
2024
Q2
$781K Sell
29,605
-6,822
-19% -$189K ﹤0.01% 1336
2024
Q1
$1.11M Buy
36,427
+8,259
+29% +$243K ﹤0.01% 1230
2023
Q4
$791K Buy
+28,168
New +$774K ﹤0.01% 1070
2023
Q3
Sell
-25,788
Closed -$793K 1658
2023
Q2
$793K Buy
25,788
+943
+4% +$31.9K ﹤0.01% 996
2023
Q1
$893K Buy
24,845
+689
+3% +$25.5K ﹤0.01% 1027
2022
Q4
$954K Buy
24,156
+177
+0.7% +$7.39K 0.01% 707
2022
Q3
$963K Buy
23,979
+520
+2% +$22.2K 0.01% 530
2022
Q2
$987K Buy
23,459
+2,567
+12% +$105K 0.01% 553
2022
Q1
$813K Buy
+20,892
New +$820K 0.01% 483

Other funds holding RPRX